G207

A neuroattenuated, replication-competent, recombinant herpes simplex virus-1 (HSV-1) with potential oncolytic activity. Upon intracerebral administration, oncolytic HSV-1 G207 preferentially replicates within glioma cells, which may elicit tumor-specific systemic immune and cytotoxic T lymphocyte (CTL) responses in addition to direct cytopathic effects. Derived from wild-type HSV-1 strain F, this agent has been neuroattenuated by deletions in both copies of the gamma34.5 gene, the major determinant of HSV neurovirulence. In addition, the HSV-1 gene UL39, encoding the viral ribonucleotide reductase large subunit infected cell protein 6 (ICP6), has been inactivated through the insertion of the Escherichia coli lacZ gene. By inactivating UL39, viral ribonucleotide reductase activity is disrupted, resulting in the inhibition of nucleotide metabolism and viral DNA synthesis in nondividing cells but not in dividing cells. (NCI Thesaurus)

YOU MAY ALSO LIKE

G2/Mitotic-Specific Cyclin-B2

G2/mitotic-specific cyclin-B2 (398 aa, ~45 kDa) is encoded by the human CCNB2 gene. This protein plays a role in the regulation of…

G2/Mitotic-Specific Cyclin-B1

G2/mitotic-specific cyclin-B1 (433 aa, ~48 kDa) is encoded by the human CCNB1 gene. This protein plays a role in mediating the progression…

G2/M Checkpoint Pathway

The G2/M DNA damage checkpoint prevents the cell from entering mitosis (M phase) if the genome is damaged. The Cdc2-cyclin B kinase…

G2 to M Transition Process

Progression from G2 phase to M phase of the standard mitotic cell cycle. (From Gene Ontology)

G2 Phase Process

Phase of the cell cycle following DNA synthesis and preceding mitosis (Gap 2 phase). The chromosomes are tetraploid in this phase. …

G17DT Immunogen

An immunotoxin composed of the hormone gastrin linked to diphtheria toxin.